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Introduction
Histoplasmosis has worldwide distribution, occurring most 
commonly in North, Central, and South America, as well as parts 
of Africa and Asia [1, 2]. Histoplasmosis is a granulomatous 
disease caused by a dimorphic fungus Histoplasma capsulatum 
(H. capsulatum).  There are two varieties of H. capsulatum that 
are pathogenic to humans, H. capsulatum var. capsulatum and 
H. capsulatum var. duboisii. H. capsulatum var. capsulatum is 
endemic in eastern United States and Latin America [3], and H. 
capsulatum var. duboisii is prevalent in Africa and South East 
Asia [4]. In the United States, H. capsulatum is primarily seen in 
Mississippi and Ohio River valleys. H. capsulatum grows best in 
soil contaminated with bird or bat droppings [5]. Transmission 
occurs via inhalation of H. capsulatum spores from the soil. 
Sites commonly associated with exposure to H. capsulatum 
include old buildings, caves, bridges, where birds have roosted 
[6, 7]. Infection may be acquired from exposure to outdoor 
activities such as exploring caves, construction, remodeling, 
demolition, bird handling, all of which can cause inhalation of 
the pathogen through the contaminated soil [8, 9]. The variation 
in clinical course due to histoplasmosis depends on the extent 
of the exposure to the organism. Histoplasmosis may remain 
asymptomatic in most healthy individuals following low-level 
exposure and asymptomatic pulmonary histoplasmosis is the 
most common syndrome following infection [10]. Fewer than 
five percent of exposed individuals develop symptomatic disease 
after a low level exposure to H. capsulatum [11]. Symptomatic 
infection usually causes self-limited pulmonary illnesses, 
rheumatologic manifestations such as arthritis or arthralgia 
involving the large or small joints, dermatologic manifestations 
such as erythema nodosum and/or erythema multiforme or 
pericarditis. Exposure to heavy inoculum can cause diffuse 
pulmonary involvement [12]. Individuals at the extremes of 
age or with underlying immunosuppressive conditions can 
develop progressive disseminated disease. Histoplasmosis can 
involve every organ system during the course of dissemination 
[13]. Here, we describe a case of pulmonary histoplasmosis 
in a healthy adult female presenting with cough, dyspnea, 
pulmonary nodule and rheumatologic manifestations. 
Case Report
A middle aged female, former smoker, outdoor worker with 
exposure to pigeons and their excreta, otherwise with no 
significant past medical history, presented to her primary 
care physician with two months history of poly-arthralgia and 
myalgia, intermittent dry cough, chest tightness, exertional 
dyspnea, malaise, fatigue and one week history of skin rash 
consisting of multiple targetoid appearing erythematous 
papules of size 0.5-1.0 cm, on  both of her hands as well as her 
thighs and lower legs. Photograph of the rash on both of her 
lower extremities is shown in (Figure 1).
Vital signs during her initial visit to primary care doctor were 
temperature 97.5º F, heart rate 82 beats per minute, respiratory 
rate 16 breaths per minute, blood pressure 132/78 mm Hg, 
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and oxygen saturation 98% on room air. On physical exam, 
she had a skin rash with description as noted above, otherwise 
she had no respiratory distress, no lymphadenopathy, no joint 
swelling or tenderness. Examination of the respiratory system, 
cardiovascular system, abdomen, central nervous system was 
noted to be unremarkable.
Initial diagnostic laboratory work up showed leucocyte count 
of 9,100 cells/mm3 (no eosinophilia), hemoglobin 14.3 g/dl, 
hematocrit 44.3% and platelet count 295,000/mm3. Serum 
electrolytes, renal function, liver function tests, and lipid screen 
were normal. Urinalysis was negative for protein or blood. 
Rapid Streptococcus group A antigen test and Influenza test for 
A & B antigens were negative. Chest X-ray (CXR) showed new 
linear opacity best seen on the lateral view in the region of the 
lingula with differential of fluid or fat within the major fissure 
versus small infiltrate in the lingula (Figure 2).  
High resolution chest computed tomographic (CT) scan was 
obtained revealing a linear density seen on the initial chest x-ray 
corresponding to a small amount of fat seen extending into the 
right major fissure, otherwise no residual infiltrate was noted. 
In the right lower lobe, posteriorly, there was a nonspecific 
sub-pleural nodule measuring about 8 mm in size. It was new 
since the prior chest computed tomographic (CT) scan obtained 
seven years ago. Remaining lungs were clear with no evidence of 
interstitial lung disease, ground-glass infiltrate, bronchiectasis, 
honeycombing or air trapping. Right para-tracheal node was 
present. No other mediastinal, hilar, or axillary nodes were 
seen. (Figure 3). 
PET/CT skull base to mid-thigh was obtained that showed 
minimal level of metabolic activity at the site of the right lung 
pulmonary nodule, and hypermetabolic sub-carinal and right 
para-tracheal lymph nodes (Figure 4).  An infectious process, 
including possible fungal disease, or malignancy were suspected.
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Fig. 1 Skin rash consisting of multiple scattered targetoid appearing 
erythematous papules of size 0.5-1.0 cm on bilateral lower extremities. 
Fig. 2 Initial Chest X-ray (CXR) PA and Lateral showing linear opacity 
best seen on the lateral view in the region of the lingula with differential 
of fluid or fat within the major fissure versus small infiltrate in the lingula.
Fig. 3 Chest computed tomographic (CT) scan showing sub-pleural 
nodule measuring about 8 mm in size in the posterior aspect of right lower 
lobe.
A referral to dermatology was made and a punch biopsy of 
the skin rash from her right dorsal thigh was performed. 
Hematoxylin & Eosin (H &E) stained section of the specimen 
showed histiocytes in the dermis arranged in rings, and 
distributed in discrete foci throughout the dermis. Granular 
and fibrillary mucinous material was present in the foci of a 
histiocytic aggregation. In addition, there was superficial and 
deep perivascular lymphocytic infiltrate, with likely diagnosis of 
granuloma annulare. She was placed on five week course of a 
low dose oral prednisone taper with some improvement noted 
in her skin rash and joint symptoms.   
During the subsequent weeks, due to non-resolution and 
persisting nature of her symptoms, she had several follow up visits 
with her primary care physician. She received several rounds of 
different oral antibiotics without significant improvement in 
her symptoms. In an effort to establish a diagnosis, extensive 
laboratory work up including rheumatologic/autoimmune and 
endocrine work up was performed which included CPK, aldolase, 
lactic acid, complement fixation tests, rheumatoid factor, 
antinuclear antibody, anti-neutrophil cytoplasmic antibody 
screen (MPO & PR3), SS-A/Ro and SS-B/La, ENA antibodies, 
Sm/RNP, dsDNA, CCP antibody, anti-glomerular basement 
membrane antibody, monoclonal protein, thyroid function 
panel, thyroid peroxidase (TPO), thyroglobulin antibody, 
parathyroid hormone (PTH intact), Insulin-Like Growth I (IGF-
1), adrenocorticotropic hormone (ACTH), serum cortisol, serum 
ferritin, iron/UIBC/transferrin saturation, vitamin B1, B6, B12 
and Vitamin D (25-Hydroxy) levels and ACE level. All of the 
above laboratory work up was unremarkable. C-reactive protein 
(CRP) was mildly elevated at 6.44 (<5.0 mg/L is considered 
normal), Erythrocyte Sedimentation Rate (ESR) was normal.
Additional laboratory work up including human 
immunodeficiency virus serology, syphilis screen, acute 
hepatitis panel, urine Histoplasma antigen, serum (1→3)-β-D-
glucan, serum fungal serology by immunodiffusion, fungal 
blood cultures, serum interferon gamma release assay, were also 
negative.
A bronchoscopy was performed and it did not reveal any 
endobronchial lesions. Endobronchial ultrasound (EBUS) scope 
was introduced and a systematic survey of the mediastinal 
lymph nodes was conducted. This revealed enlarged lymph 
nodes in stations 7 and 11R. Endobronchial ultrasound-guided 
transbronchial needle aspiration (EBUS-TBNA) of mediastinal 
lymph nodes was performed. The adequacy of the specimens 
was confirmed with rapid onsite pathology. Following this, 
endobronchial specimens, endobronchial brushing and 
bronchoalveolar lavage (BAL) were obtained from right lower 
lobe, right and left upper lobes.
Biopsy of the mediastinal lymph nodes, bronchial brushing & 
BAL cytology were negative for malignancy. Stains for acid-
fast bacilli were negative. Stained section of mediastinal 
lymph node showed numerous lymphocytes, histiocytes, many 
multinucleated giant cells, forming necrotizing granuloma. 
Grocott’s Methenamine Silver (GMS) stain also revealed the 
presence of small uniform black yeast forms of approximately 
2 to 4 µm in size (Figure 5). Some of these yeast forms showed 
narrow-based budding, overall morphology was consistent 
with Histoplasma. Gram’s stain of BAL and biopsy specimens 
showed rare while blood cells, no organisms. Aerobic, anaerobic, 
acid fast bacilli and fungal cultures were negative. BAL viral 
respiratory panel was negative. 
The patient was started on oral itraconazole for twelve weeks. 
She tolerated the treatment well and successfully completed 
her 12-week course of itraconazole for histoplasmosis with 
significant improvement in her symptoms.
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Fig. 4 PET/CT skull base to mid-thigh showing hypermetabolic sub-
carinal and right para-tracheal lymph nodes. 
Fig. 5 Photomicrograph: Grocott’s Methenamine Silver (GMS) stained 
section of mediastinal lymph node showing necrotizing granuloma 
containing small uniform black yeast forms of approximately 2 to 4 µm 
size with narrow based budding consistent with Histoplasma (GMS stain, 
60X). 
Discussion
In this case report, we have described a case of pulmonary 
histoplasmosis in a healthy adult female living in Kentucky 
who presented with cough, dyspnea, pulmonary nodule and 
rheumatologic manifestations. This review focuses on the 
epidemiological, clinical, diagnostic, and therapeutic aspects of 
histoplasmosis. 
Epidemiology
Histoplasmosis is a systemic mycotic infection caused by 
Histoplasma capsulatum [14].  It has two distinct pathogenic 
forms H. capsulatum var. capsulatum which is endemic in 
eastern United States and Latin America [3], and H. capsulatum 
var. duboisii which is prevalent in Africa and South East Asia [4]. 
Histoplasmosis is among the most common endemic mycosis in 
the United States with the largest burden of disease occurring 
in mid-western states around the Ohio and upper Mississippi 
River Valleys [13]. In the United States, an estimated 60% 
to 90% of people who live in areas surrounding the Ohio and 
Mississippi River valleys (where Histoplasma is common in the 
environment) have been exposed to the fungus at some point 
during their lifetime [15]. State-specific annual incidence rates 
in the mid-west range from 0 to 4.3 cases/100,000 population 
[16]. Our case is a good example of pulmonary histoplasmosis in 
an immunocompetent individual living around the Ohio River 
Valley which is endemic for Histoplasmosis. 
Mycology
Histoplasma capsulatum is a dimorphic fungus. The organism 
exists in the mold (mycelial) form in the soil and switches to 
the yeast form at normal human body temperatures. It finds 
a natural habitat in soil with high nitrogen content such as 
areas contaminated by bird or bat excrements. Birds do not 
transmit the disease; however, bird excretions contaminate the 
soil, thereby enriching the growth medium for the mycelium. 
Contaminated soil can be potentially infective for years [17].
Pathogenesis
During outdoor activities, H. capsulatum enters the human 
host by inhalation of fungal conidia or mycelia fragment. 
Once inhaled these fungal elements convert to the yeast form 
and replicate within the macrophages, and then spread to the 
regional lymph nodes, and throughout the reticuloendothelial 
system via parasitized macrophages [18]. Macrophages initially 
are able to ingest but not kill the fungi [19, 20].  The infected 
macrophages induce inflammatory response and recruit more 
macrophages, lymphocytes and plasma cells to destroy the 
organism and arrest infection. These coalesce together to 
form granulomas consisting of giant cells with central caseous 
necrosis, which further undergoes fibrosis and calcification [21]. 
Even with the development of cell-mediated immunity, patients 
can have remaining foci of viable H. capsulatum in various 
organs, similar to tuberculosis. These organisms are held in 
check by the immune response but are not completely killed, 
and thus, reactivation of infection years later is possible [13]. 
Clinical Manifestations
Clinical findings of histoplasmosis are varied, and the disease 
should be considered in the following clinical presentations, 
particularly in the appropriate epidemiologic setting: 
Pneumonia with mediastinal or hilar lymphadenopathy, 
mediastinal or hilar masses suggestive of malignancy or 
tuberculosis, pulmonary nodule suggestive of malignancy, 
cavitary lung disease suggestive of tuberculosis, pericarditis with 
mediastinal lymphadenopathy, pulmonary manifestations with 
arthritis or arthralgia plus erythema nodosum, and suspected 
sarcoidosis [22].
In most healthy individuals, the most common outcome after 
low-level exposure is asymptomatic pulmonary histoplasmosis 
[10].  Asymptomatic cases are usually identified based 
upon incidental chest imaging findings such as abnormal 
radiographs or computed tomographic (CT) scans showing 
enlarged mediastinal or hilar lymphadenopathy or pulmonary 
nodules. Less than five percent of exposed individuals develop 
symptomatic disease after a low-level exposure to H. capsulatum 
[11]. Symptomatic pulmonary histoplasmosis, as noted in our 
case report, presents as a subacute pulmonary infection weeks 
to months following exposure. Symptoms are usually mild, and 
may be accompanied by rheumatologic and/or dermatologic 
manifestations or pericarditis in approximately 5% of patients 
[13]. Myalgia and arthralgia are common symptoms during 
acute infection and appear to be more common in women 
[23]. The arthritis is poly-articular and usually symmetric and 
involves large or small joints [23]. Joint symptoms usually 
resolve spontaneously over several weeks and respond to 
nonsteroidal anti-inflammatory agents. About fifty percent of 
the patients with joint symptoms develop skin lesions. Erythema 
nodosum and erythema multiforme are the most common skin 
manifestations [24, 25]. They occur most frequently in women 
and are thought to be associated with a hypersensitivity response 
to the antigens of H. capsulatum [24-26]. Our patient presented 
with cough, dyspnea and pulmonary nodule accompanied with 
rheumatologic manifestations. Patients who live in endemic 
area and present with above clinical features, histoplasmosis 
should be strongly considered in the differential diagnosis, and 
appropriate diagnostic work up should be performed.  
Patients who inhale a large inoculum can develop a severe and 
potentially fatal acute diffuse pulmonary infection [10, 27-30]. 
The onset of illness is abrupt, symptomatic infection can occur 
within a week or two [31-33], presenting with fever, chills, 
malaise, dyspnea, cough, and chest pain. Chest radiographs 
show diffuse reticulo-nodular or miliary pulmonary infiltrates. 
Disease can progress to respiratory failure or progressive 
extrapulmonary dissemination [28, 34-35]. Acute respiratory 
distress syndrome can occur within a few days [28-29]. 
Mediastinal granuloma or granulomatous mediastinitis is a 
rare complication of pulmonary histoplasmosis. Mediastinal 
lymphadenopathy is common in acute histoplasmosis. However, 
instead of enlargement of a few nodes that eventually recede and 
ultimately calcify as the host handles the infection, mediastinal 
granuloma is characterized by enlarging, encapsulated, caseous 
mediastinal lymph nodes which can remain enlarged for months 
to even years. Yeast forms of H. capsulatum can sometimes be 
seen in the midst of necrotic material that is obtained by needle 
aspiration or tissue biopsy [13]. 
Many patients are asymptomatic, and the nodes are discovered 
on a chest radiograph or computed tomographic (CT) scan of 
the chest. Radiographs show enlarged hilar, sub-carinal, or 
para-tracheal lymph nodes. However, others may experience 
variety of symptoms including chest pain, cough, hemoptysis, 
and dyspnea due to encroachment of this mass of nodes around 
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mediastinal structures such as esophagus, pulmonary vessels 
and superior vena cava [10, 36-39]. Rarely, the nodes may 
drain spontaneously into the adjacent soft tissues of neck or 
airways causing broncho-esophageal or trachea-esophageal 
fistula or even the pericardium [10, 37, 40-41]. Chest imaging 
findings in our patient showed mediastinal lymphadenopathy 
but no characteristic findings of granulomatous mediastinitis 
mentioned above were noted.
The development of disease associated with the initial 
dissemination of H. capsulatum is dependent on the host. 
Patients who are immunosuppressed and are unable to develop 
effective cell-mediated immunity against the organism are likely 
to manifest symptomatic disease during the period of acute 
dissemination.  Progressive, clinically evident dissemination 
occurs primarily in patients with underlying immunosuppressive 
disorders. This includes patients with AIDS, hematologic 
malignancies, organ transplant recipients, or those who are on 
medications such as corticosteroids [8, 42-46].
Differential Diagnosis
Differential diagnosis of acute pulmonary histoplasmosis 
includes acute pulmonary blastomycosis, coccidioidomycosis, 
and atypical community-acquired pneumonias, such as those 
due to Mycoplasma, Legionella, and Chlamydia. Our patient’s 
initial clinical presentation was thought to be due to bacterial 
community acquired pneumonia, however our patient failed 
to respond to multiple courses of different oral antibiotic 
therapy. Hilar or mediastinal lymphadenopathy is common 
with histoplasmosis and can be seen with blastomycosis but 
would be extremely uncommon with community-acquired 
pneumonia caused by Mycoplasma, Legionella and Chlamydia. 
Other possibilities include conditions in which parasitized 
macrophages are seen, such as leishmaniasis and Penicillium 
marneffei infections [47]. The parasites in leishmaniasis lack 
the clear halo seen in H. capsulatum and tend to aggregate at 
the periphery of the macrophage (marquee sign).  Leishmania 
donovani (LD) bodies can be distinguished by a nucleus and 
bar-shaped kinetoplast within each amastigote and it is negative 
for Periodic acid–Schiff (PAS) stain [47]. The Penicillium 
marneffei yeast forms replicate by binary division and have a 
septate appearance, whereas H. capsulatum divides by narrow-
based budding [47]. In the case of histoplasmosis, as noted in 
our case report, numerous small 2–4 µm in diameter yeast-like 
microorganisms may be seen within macrophage, multinucleate 
giant cells, or within fibrous tissue [48]. Patients who have hilar 
lymphadenopathy, arthralgia, and erythema nodosum can be 
mistakenly given the diagnosis of sarcoidosis [49, 50]. Also, the 
early clinical manifestations of disseminated histoplasmosis 
are nonspecific, often leading to diagnostic difficulty and 
misdiagnosis as tuberculosis, lymphoma or metastatic 
malignancy [51]. Thus, in the appropriate epidemiologic setting, 
testing for histoplasmosis should be included for patients who 
are under evaluation for these aforementioned conditions.   
Diagnosis
Health care providers must be aware of the clinical syndromes 
and a careful history of possible exposure to H. capsulatum, 
epidemiologic clues, namely activities of daily living, travel 
and occupations that expose the patient to sites contaminated 
with bat or bird droppings are crucial to arriving at the correct 
diagnosis. Also, clinicians must be familiar with the uses and 
limitations of the diagnostic tests for fungal diseases. 
The clinical picture, chest radiographic findings and 
histopathology using stains for fungi, cultures, antigen detection, 
and serologic tests for Histoplasma-specific antibodies can all 
help make the diagnosis of pulmonary histoplasmosis [52].
Detection of polysaccharide antigen by enzyme immunoassay 
(EIA) in either the urine, blood, or bronchoalveolar lavage fluid 
is useful in clinically ill patients in need of a quick diagnosis. 
Most studies have been performed using a commercial test that 
is currently available in the United States. In these studies, an H. 
capsulatum galactomannan can be detected in 60 to 83 percent 
of patients with acute pulmonary histoplasmosis [52, 53]. The 
highest sensitivity is obtained by testing both urine and serum 
[54]. Our patient had a negative urine Histoplasma antigen test. 
False-positive reactions for Histoplasma antigen in urine are 
common among patients who have other endemic mycoses such 
as blastomycosis, penicilliosis, and paracoccidioidomycosis. 
In one study, 8 of 9 patients with paracoccidioidomycosis, 12 
of 19 with blastomycosis, and 17 of 18 with penicilliosis had 
urine antigen tests that were positive for Histoplasma antigen 
[55]. In North America, there is little concern about this lack of 
specificity, except for those patients who have blastomycosis, 
because only the areas of endemicity of histoplasmosis and 
blastomycosis overlap [56]. 
Although not an antigen test, detection of (1→3)-β-D-glucan 
(BG) in serum has been shown to be a useful adjunct for 
diagnosis of invasive fungal infections, especially candidiasis, 
aspergillosis, pneumocystosis, and histoplasmosis [57-59]. The 
sensitivity of the test was 87% in histoplasmosis cases and it 
had a specificity of 68% with controls. Histoplasmosis should 
be considered as a possible cause for a positive BG test, but 
such results may be found with many other conditions that are 
clinically similar to this fungal disease [60]. Our patient had a 
negative BG test. 
Serologic tests for antibodies provide the basis for diagnosis 
in patients with mild infections, but require at least a month 
to appear after the initial exposure. Also, serologic testing may 
not be reliable in patients without a compatible clinical picture 
or epidemiologic risk factors. The standard assays are the 
complement fixation (CF) test that uses two separate antigens, 
yeast and mycelial (or histoplasmin), and the immunodiffusion 
(ID) assay. Less than 1 percent of residents in endemic areas 
are seropositive by the immunodiffusion test and less than 
five percent have positive complement fixation assays [61]. 
Diagnosis is based on a fourfold rise in CF antibody titer; a 
single titer of 1:32 is suggestive but not diagnostic. CF antibodies 
persist for years after infection; thus, the presence of a single 
low CF titer means little other than that the patient was exposed 
to H. capsulatum at some time [13]. The CF test appears to be 
less specific than the ID assay; False-positive CF tests occur in 
patients with lymphoma, tuberculosis, sarcoidosis, and other 
fungal infections, all of which may present as a mediastinal mass 
[13, 62-63]. Tissue biopsy is always required in these instances. 
Antibody assays may be falsely negative in immunosuppressed 
patients. Antibodies can remain positive for several years and 
thus may not indicate disease activity [61]. For those patients 
who have mediastinal lymphadenopathy, antibody assays 
may or may not be positive and cannot be relied upon to 
make a definitive diagnosis. Our patient had a negative serum 
Histoplasma antibody by immunodiffusion test.  
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The role of polymerase chain reaction (PCR) for diagnosis of 
histoplasmosis is uncertain. Several laboratories are working 
on developing PCR assays that might help with a more rapid 
identification of H. capsulatum [64-66]. In one study, PCR was 
less sensitive and was positive in only 8% of urine specimens 
from patients with histoplasmosis [67]. In another study, 
PCR was negative in one third of tissues in which yeast was 
seen by histopathology [68]. Currently there are no validated, 
and commercially available PCR methods for diagnosis of 
histoplasmosis.
Fungal cultures can be sent from infective material such as 
blood, bone marrow or sputum, and they should be observed 
for 6–8 weeks before they may be considered negative. They 
are useful in patients with chronic pulmonary histoplasmosis 
and submission of multiple sputum or bronchoalveolar lavage 
cultures produces a positive yield in the majority of cases [69]. 
The sensitivity of respiratory cultures is much lower in localized 
disease or acute disease [70]. Samples of tissue or body fluids 
sent to the laboratory for culture are plated onto Sabouraud’s 
dextrose agar (SDA) and incubated at 25°C to allow for growth 
of the mycelial phase of H. capsulatum. After several weeks, 
and sometimes as long as 6 weeks, growth of a white to light 
tan mold occurs. Two types of conidia are produced on the 
hyphae. The macroconidia, or tuberculate conidia, are 8 to 
15 m in diameter and have distinctive projections on their 
surface; the microconidia are small (2 to 4 m) and smooth 
walled. Identification of the tuberculate macroconidia allows 
a presumptive diagnosis of histoplasmosis. A definitive test 
to verify that the mold is H. capsulatum should always be 
performed. There is a commercially available chemiluminescent 
DNA probe which can be used for definitive identification of H. 
capsulatum [71].
Morphologic findings in biopsy specimens include granulomas, 
lymphohistiocytic aggregates, and diffuse mononuclear cell 
infiltrates. Histopathologic examination of lung or mediastinal 
lymph node tissue using special stains may show yeast-
phase organisms of Histoplasma, measuring 2 to 4 micron in 
diameter, with narrow based budding (as noted in Figure 5 of 
our case report). Cultures are usually negative.  Other organisms 
can mimic the appearance of H. capsulatum in tissues such as 
Candida glabrata, Cryptococcus neoformans, Pneumocystis 
jirovecii and Leishmania, but radiological and clinical picture 
will generally separate histoplasmosis from the others [13].
Treatment
Most infections caused by H. capsulatum are self-limited 
and require no therapy. However, patients who are exposed 
to a large inoculum of Histoplasma and those who are 
immunocompromised usually require antifungal therapy [22] 
Amphotericin B, Itraconazole, voriconazole, posaconazole, 
isavuconazole and fluconazole, all have in vitro activity against 
H. capsulatum. Itraconazole is generally preferred for mild to 
moderate histoplasmosis, and amphotericin B has a role in the 
treatment of moderately severe and severe infections [72]. 
The Infectious Diseases Society of America (IDSA) has 
published clinical practice guidelines that are based upon 
open-label studies, case reports, and expert opinion [72]. 
According to a 2007 update by the Infectious Disease Society 
of America clinical practice guidelines for the management of 
histoplasmosis, no treatment is recommended for patients with 
asymptomatic mediastinal granuloma as self-resolution may 
occur. The recommendation for symptomatic patients is medical 
management alone with 6–12 weeks of oral itraconazole [72]. 
For moderately severe to severe acute pulmonary histoplasmosis, 
lipid formulation of amphotericin B (3.0–5.0 mg/kg daily 
intravenously for 1–2 weeks) followed by oral itraconazole (200 
mg 3 times daily for 3 days and then 200 mg twice daily, for a 
total of 12 weeks) is recommended [72]. 
For mild-to-moderate acute pulmonary histoplasmosis, 
treatment is usually unnecessary. Oral itraconazole (200 mg 3 
times daily for 3 days and then 200 mg once or twice daily for 
6–12 weeks) is recommended for patients who continue to have 
symptoms for >1 month [72]. 
Treatment for asymptomatic pulmonary nodules 
(histoplasmomas) or mediastinal adenopathy is usually 
not indicated [51]. In the presence of persistent symptoms, 
accompanied by positive antigen tests, CF titers of 1:32 or 
higher, histopathology showing yeast resembling H. capsulatum 
or positive cultures, oral itraconazole treatment may be 
appropriate if no symptomatic improvement occurs after 1 
month of observation [12]. Our patient had persisting symptoms 
for 2 months and histopathology of mediastinal lymph node 
showed necrotizing granuloma and Grocott’s Methenamine 
Silver (GMS) stain also revealed the presence of yeast forms 
with narrow-based budding consistent with Histoplasma. She 
was treated with oral itraconazole for 12 weeks with significant 
improvement in her symptoms. 
Arthritis or arthralgia with erythema nodosum occurs in 5%–
10% of cases as a systemic inflammatory response to acute 
pulmonary histoplasmosis [24, 27]. These manifestations do 
not represent infection, and they respond to nonsteroidal anti-
inflammatory agents without antifungal therapy. In some cases, 
the manifestations are moderately severe, requiring treatment 
with corticosteroids [27]. If corticosteroids are used, concurrent 
itraconazole treatment is recommended to reduce the risk of 
progressive infection.
Prevention
There is no vaccine against histoplasmosis. In areas where the 
fungus is common, it may not be possible to prevent infection. 
Pets, particularly cats & dogs, can get histoplasmosis, but it is 
not contagious between animals and people [73]. Birds don’t 
appear to be able to get histoplasmosis. It may be difficult to 
avoid inhaling the spores of Histoplasma in the areas where it 
is endemic. Avoiding areas with bird and bat droppings may 
provide some protection. Wearing a respirator face mask can 
provide protection for workers in contaminated areas. 
Conclusion
In conclusion, we report a case of pulmonary histoplasmosis in 
a patient presenting with cough, dyspnea, pulmonary nodule 
and rheumatologic manifestations. Our case highlights the fact 
that histoplasmosis can present with variable manifestations 
in immunocompetent individuals living in endemic region 
for histoplasmosis. Our patient presented with nonspecific 
symptoms with a vast differential diagnosis prompting a thorough 
work up and eventually leading to endobronchial ultrasound-
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guided transbronchial needle aspiration cytology (EBUS-
TBNA) of mediastinal lymph nodes demonstrating necrotizing 
granuloma with fungal stains positive for Histoplasma. Patient 
was treated with antifungal therapy and showed significant 
clinical improvement. This fungal disease accounts for a good 
number of cases of nonspecific flulike illness especially in 
endemic areas, but its inconsistent clinical manifestations 
often hinder a straightforward diagnosis. Thus, a high degree 
of suspicion and epidemiological reasoning on the part of the 
health care providers is required to consider histoplasmosis in 
differential diagnosis. In this context, our case report illustrates 
the following points: 1) cough, dyspnea and pulmonary nodule 
(accompanied with rheumatologic and/or skin manifestations) 
in patients especially living in the endemic areas should always 
alert the clinician of the possibility of histoplasmosis. 2) Starting 
oral antifungal therapy (Itraconazole) may lead to favorable 
outcomes in patients presenting with pulmonary nodule and/
or mediastinal lymphadenopathy with persisting symptoms 
for more than one month and histopathology showing yeast 
resembling H. capsulatum.
Funding Source: No financial support
Conflict of Interest: All authors declared no conflict of 
interest in relation to the main objective of this work.
References
1. Bahr NC, Antinori S, Wheat LJ, Sarosi GA. Histoplasmosis 
infections worldwide: thinking outside of the Ohio River 
valley. Curr Trop Med Rep. 2015;2(2):70-80. doi:10.1007/
s40475-015-0044-0
2. Colombo AL, Tobón A, Restrepo A, Queiroz-Telles F, Nucci 
M. Epidemiology of endemic systemic fungal infections in 
Latin America. Med Mycol. 2011;49(8):785-798.
3. Anstead GM, Patterson TF. Endemic mycoses. In: Anaissie 
EJ, McGinnis MR, Pfaller MA, eds. Clinical Mycology. 
2nd ed. Philadelphia, PA: Churchill Livingstone Elsevier; 
2009:355-373. doi:10.1016/B978-1-4160-5680-5.00015-3
4. Kauffman CA. Histoplasmosis. In: Dismukes WE, Pappas 
PG, Sobel JD, eds. Clinical Mycology. Oxford, UK: Oxford 
University Press; 2003:285-298.
5. Murray JF, Mills J. Pulmonary infectious complications 
of human immunodeficiency virus infection. Part II. Am 
Rev Respir Dis. 1990;141(6):1582-1598. doi:10.1164/
ajrccm/141.6.1582
6. Cano MV, Hajjeh RA. The epidemiology of histoplasmosis: 
a review. Semin Respir Infect. 2001;16(2):109-118. 
doi:10.1053/srin.2001.24241
7. Jones TF, Swinger GL, Craig AS, McNeil MM, Kaufman L, 
Schaffner W. Acute pulmonary histoplasmosis in bridge 
workers: a persistent problem. Am J Med. 1999;106(4):480-
482. doi:10.1016/S0002-9343(99)00044-3
8. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. 
Disseminated histoplasmosis in the acquired immune 
deficiency syndrome: clinical findings, diagnosis and 
treatment, and review of the literature. Medicine 
(Baltimore). 1990;69(6):361-374. doi:10.1097/00005792-
199011000-00004
9. Hajjeh RA. Disseminated histoplasmosis in persons 
infected with human immunodeficiency virus. Clin Infect 
Dis. 1995;21(suppl 1):S108-S110. doi:10.1093/clinids/21.
Supplement_1.S108
10. Goodwin RA, Loyd JE, Des Prez RM. Histoplasmosis in 
normal hosts. Medicine (Baltimore). 1981;60(4):231-266. 
doi:10.1097/00005792-198107000-00001
11. Wheat LJ. Diagnosis and management of histoplasmosis. 
Eur J Clin Microbiol Infect Dis. 1989;8(5):480-490. 
doi:10.1007/BF01964063
12. Hage CA, Wheat LJ, Loyd J, Allen SD, Blue D, Knox KS. 
Pulmonary histoplasmosis. Semin Respir Crit Care Med. 
2008;29(2):151-165. doi:10.1055/s-2008-1063854
13. Kauffman CA. Histoplasmosis: a clinical and laboratory 
update. Clin Microbiol Rev. 2007;20(1):115-132. 
doi:10.1128/CMR.00027-06
14. Mignogna MD, Fedele S, Lo Russo L, Ruoppo E, Lo 
Muzio L. A case of oral localized histoplasmosis in an 
immunocompetent patient. Eur J Clin Microbiol Infect 
Dis. 2001;20(10):753-755. doi:10.1007/s100960100592
15. Manos NE, Ferebee SH, Kerschbaum WF. Geographic 
variation in the prevalence of histoplasmin sensitivity. Dis 
Chest. 1956;29(6):649-668. doi:10.1378/chest.29.6.649
16. Armstrong PA, Jackson BR, Haselow D, et al. Multistate 
Epidemiology of Histoplasmosis, United States, 2011-
2014. Emerg Infect Dis. 2018;24(3):425-431. doi:10.3201/
eid2403.171258
17. Chang RC, Susanto I. Histoplasmosis. e-medicine 
J. available from http://www.emedicine.com/med/
topic1021. 2007
18. Goodwin RA Jr, Shapiro JL, Thurman GH, Thurman 
SS, Des Prez RM. Disseminated histoplasmosis: clinical 
and pathologic correlations. Medicine (Baltimore). 
1980;59(1):1-33. doi:10.1097/00005792-198001000-
00001
19. Horwath MC, Fecher RA, Deepe GS Jr. Histoplasma 
capsulatum, lung infection and immunity. Future 
Microbiol. 2015;10(6):967-975. doi:10.2217/fmb.15.25
20. Garfoot AL, Zemska O, Rappleye CA. Histoplasma 
capsulatum depends on de novo vitamin biosynthesis 
for intraphagosomal proliferation. Infect Immun. 
2014;82(1):393-404. doi:10.1128/IAI.00824-13
21. Sareen R, Kapil, M, Gupta GN, Govil A. Disseminated 
histoplasmosis in an immunocompetent individual 




23. Rosenthal J, Brandt KD, Wheat LJ, Slama TG. 
Rheumatologic manifestations of histoplasmosis in 
the recent Indianapolis epidemic. Arthritis Rheum. 
1983;26(9):1065-1070. doi:10.1002/art.1780260902
24. Ozols II, Wheat LJ. Erythema nodosum in an 
epidemic of histoplasmosis in Indianapolis. Arch 
Dermatol. 1981;117(11):709-712. doi:10.1001/
archderm.1981.01650110031014
25. Sellers TF Jr, Price WN Jr, Newberry WM Jr. An epidemic 
of erythema multiforme and erythema nodosum caused by 
histoplasmosis. Ann Intern Med. 1965;62(6):1244-1262. 
doi:10.7326/0003-4819-62-6-1244
26. Medeiros AA, Marty SD, Tosh FE, Chin TDY. Erythema 
nodosum and erythema multiforme as clinical 
manifestations of histoplasmosis in a community outbreak. 
N Engl J Med. 1966;274(8):415-420. doi:10.1056/
NEJM196602242740801
51ULJRI Vol 2, (2) 2018
27. Benedict K, Mody RK. Epidemiology of Histoplasmosis 
Outbreaks, United States, 1938-2013. Emerg Infect Dis. 
2016;22(3):370-378. doi:10.3201/eid2203.151117
28. Kataria YP, Campbell PB, Burlingham BT. Acute 
pulmonary histoplasmosis presenting as adult respiratory 
distress syndrome: effect of therapy on clinical and 
laboratory features. South Med J. 1981;74(5):534-537, 542. 
doi:10.1097/00007611-198105000-00007
29. Wynne JW, Olsen GN. Acute histoplasmosis presenting 
as the adult respiratory distress syndrome. Chest. 
1974;66(2):158-161. doi:10.1378/chest.66.2.158
30. Wheat LJ, Kauffman CA. Histoplasmosis. Infect Dis 
Clin North Am. 2003;17(1):1-19, vii. doi:10.1016/S0891-
5520(02)00039-9
31. Wheat LJ, Conces D, Allen SD, Blue-Hnidy D, Loyd J. 
Pulmonary histoplasmosis syndromes: recognition, 
diagnosis, and management. Semin Respir Crit Care Med. 
2004;25(2):129-144. doi:10.1055/s-2004-824898
32. Gustafson TL, Kaufman L, Weeks R, et al. Outbreak of 
acute pulmonary histoplasmosis in members of a wagon 
train. Am J Med. 1981;71(5):759-765. doi:10.1016/0002-
9343(81)90361-2
33. Ward JI, Weeks M, Allen D, et al. Acute histoplasmosis: 
clinical, epidemiologic and serologic findings of an outbreak 
associated with exposure to a fallen tree. Am J Med. 
1979;66(4):587-595. doi:10.1016/0002-9343(79)91168-9
34. Paya CV, Roberts GD, Cockerill FR III. Transient fungemia 
in acute pulmonary histoplasmosis: detection by new 
blood-culturing techniques. J Infect Dis. 1987;156(2):313-
315. doi:10.1093/infdis/156.2.313
35. Rubin H, Furcolow ML, Yates JL, Brasher CA. The 
course and prognosis of histoplasmosis. Am J Med. 
1959;27(2):278-288. doi:10.1016/0002-9343(59)90347-X
36. Garrett HE Jr, Roper CL. Surgical intervention in 
histoplasmosis. Ann Thorac Surg. 1986;42(6):711-722. 
doi:10.1016/S0003-4975(10)64619-X
37. Coss KC, Wheat LJ, Conces DJ Jr, Brashear RE, Hull 
MT. Esophageal fistula complicating mediastinal 
histoplasmosis. Response to amphotericin B. Am J Med. 
1987;83(2):343-346. doi:10.1016/0002-9343(87)90709-1
38. Rabinowitz JG, Prater W, Silver J, Phillips JC, Wieder 
S. Mediastinal histoplasmosis. Mt Sinai J Med. 
1980;47(4):356-363.
39. Schowengerdt CG, Suyemoto R, Main FB. Granulomatous 
and fibrous mediastinitis. A review and analysis of 180 
cases. J Thorac Cardiovasc Surg. 1969;57(3):365-379.
40. Savides TJ, Gress FG, Wheat LJ, Ikenberry S, Hawes RH. 
Dysphagia due to mediastinal granulomas: diagnosis 
with endoscopic ultrasonography. Gastroenterology. 
1995;109(2):366-373. doi:10.1016/0016-5085(95)90322-
4
41. Sakulksy SB, Harrison EG, Dines DE, et al. Mediastinal 
granuloma. J Thorac Cardiovasc Surg. 1967;54:280.
42. Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens 
RB, Kalil AC. Histoplasmosis in solid organ transplant 
recipients at a large Midwestern university transplant 
center. Transpl Infect Dis. 2005;7(3-4):109-115. 
doi:10.1111/j.1467-8365.2005.00105.x
43. Johnson PC, Khardori N, Najjar AF, Butt F, Mansell PWA, 
Sarosi GA. Progressive disseminated histoplasmosis in 
patients with acquired immunodeficiency syndrome. 
Am J Med. 1988;85(2):152-158. doi:10.1016/S0002-
9343(88)80334-6
44. Kauffman CA, Israel KS, Smith JW, White AC, Schwarz J, 
Brooks GF. Histoplasmosis in immunosuppressed patients. 
Am J Med. 1978;64(6):923-932. doi:10.1016/0002-
9343(78)90445-X
45. Wheat LJ, Smith EJ, Sathapatayavongs B, et al. 
Histoplasmosis in renal allograft recipients. Two large 
urban outbreaks. Arch Intern Med. 1983;143(4):703-707. 
doi:10.1001/archinte.1983.00350040093012
46. Wheat LJ, Slama TG, Norton JA, et al. Risk factors for 
disseminated or fatal histoplasmosis. Analysis of a large 
urban outbreak. Ann Intern Med. 1982;96(2):159-163. 
doi:10.7326/0003-4819-96-2-159
47. Mishra DP, Ramamurthy S, Behera SK. Histoplasmosis 
presenting as isolated cervical lymphadenopathy: 
A rare presentation. J Cytol. 2015;32(3):188-190. 
doi:10.4103/0970-9371.168855
48. Tewari R, Wheat LJ, Ajello L. Agents of histoplasmosis. 
In: Ajello L, Hay RJ, eds. Medical Mycology, Topley & 
Wilson’s Microbiology and Microbial Infections. New 
York, NY: Arnold and Oxoford University Press; 1998:373-
407.
49. Thornberry DK, Wheat LJ, Brandt KD, Rosenthal J. 
Histoplasmosis presenting with joint pain and hilar 
adenopathy. “Pseudosarcoidosis”. Arthritis Rheum. 
1982;25(12):1396-1402. doi:10.1002/art.1780251202
50. Wheat LJ, French MLV, Wass JL. Sarcoidlike manifestations 
of histoplasmosis. Arch Intern Med. 1989;149(11):2421-
2426. doi:10.1001/archinte.1989.00390110027007
51. Sharma S, Kumari N, Ghosh P, Aggarwal A. Disseminated 
histoplasmosis in an immunocompetent individual--a case 
report. Indian J Pathol Microbiol. 2005;48(2):204-206.
52. Hage CA, Ribes JA, Wengenack NL, et al. A multicenter 
evaluation of tests for diagnosis of histoplasmosis. Clin 
Infect Dis. 2011;53(5):448-454. doi:10.1093/cid/cir435
53. Wheat LJ. Improvements in diagnosis of histoplasmosis. 
Expert Opin Biol Ther. 2006;6(11):1207-1221. 
doi:10.1517/14712598.6.11.1207
54. Swartzentruber S, Rhodes L, Kurkjian K, et al. Diagnosis of 
acute pulmonary histoplasmosis by antigen detection. Clin 
Infect Dis. 2009;49(12):1878-1882. doi:10.1086/648421
55. Wheat J, Wheat H, Connolly P, et al. Cross-reactivity in 
Histoplasma capsulatum variety capsulatum antigen assays 
of urine samples from patients with endemic mycoses. Clin 
Infect Dis. 1997;24(6):1169-1171. doi:10.1086/513647
56. Garner JA, Kernodle D. False-positive Histoplasma antigen 
test in a patient with pulmonary blastomycosis. Clin. Infect. 
Dis. 21:1054. 41. Gaynes, R. P., P. Gardner, and W. Causey. 
1981. Prosthetic value endocarditis caused by Histoplasma 
capsulatum. Arch Intern Med. 1995;141:1533-1537.
57. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a 
diagnostic adjunct for invasive fungal infections: validation, 
cutoff development, and performance in patients with acute 
myelogenous leukemia and myelodysplastic syndrome. 
Clin Infect Dis. 2004;39(2):199-205. doi:10.1086/421944
58. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. 
Multicenter clinical evaluation of the (1-->3) beta-D-glucan 
assay as an aid to diagnosis of fungal infections in humans. 
Clin Infect Dis. 2005;41(5):654-659. doi:10.1086/432470
59. Pickering JW, Sant HW, Bowles CAP, Roberts WL, 
Woods GL. Evaluation of a (1->3)-beta-D-glucan assay for 
diagnosis of invasive fungal infections. J Clin Microbiol. 
2005;43(12):5957-5962. doi:10.1128/JCM.43.12.5957-
5962.2005
52ULJRI Vol 2, (2) 2018
60. Egan L, Connolly P, Wheat LJ, et al. Histoplasmosis 
as a cause for a positive Fungitell (1 --> 3)-β-D-
glucan test. Med Mycol. 2008;46(1):93-95. 
doi:10.1080/13693780701642235
61. Wheat J, French ML, Kohler RB, et al. The diagnostic 
laboratory tests for histoplasmosis: analysis of experience 
in a large urban outbreak. Ann Intern Med. 1982;97(5):680-
685. doi:10.7326/0003-4819-97-5-680
62. Picardi JL, Kauffman CA, Schwarz J, Phair JP. Detection 
of precipitating antibodies to Histoplasma capsulatum 
by counterimmunoelectrophoresis. Am Rev Respir Dis. 
1976;114(1):171-176.
63. Wheat J, French MLV, Kamel S, Tewari RP. Evaluation of 
cross-reactions in Histoplasma capsulatum serologic tests. 
J Clin Microbiol. 1986;23(3):493-499.
64. Guedes HL, Guimarães AJ, Muniz MM, et al. PCR assay 
for identification of histoplasma capsulatum based on the 
nucleotide sequence of the M antigen. J Clin Microbiol. 
2003;41(2):535-539. doi:10.1128/JCM.41.2.535-539.2003
65. Martagon-Villamil J, Shrestha N, Sholtis M, et al. 
Identification of Histoplasma capsulatum from 
culture extracts by real-time PCR. J Clin Microbiol. 
2003;41(3):1295-1298. doi:10.1128/JCM.41.3.1295-
1298.2003
66. Rickerts V, Bialek R, Tintelnot K, Jacobi V, Just-
Nübling G. Rapid PCR-based diagnosis of disseminated 
histoplasmosis in an AIDS patient. Eur J Clin Microbiol 
Infect Dis. 2002;21(11):821-823. doi:10.1007/s10096-
002-0833-y
67. Tang YW, Li H, Durkin MM, et al. Urine polymerase 
chain reaction is not as sensitive as urine antigen for 
the diagnosis of disseminated histoplasmosis. Diagn 
Microbiol Infect Dis. 2006;54(4):283-287. doi:10.1016/j.
diagmicrobio.2005.10.008
68. Bialek R, Feucht A, Aepinus C, et al. Evaluation of two 
nested PCR assays for detection of Histoplasma capsulatum 
DNA in human tissue. J Clin Microbiol. 2002;40(5):1644-
1647. doi:10.1128/JCM.40.5.1644-1647.2002
69. Wheat LJ, Wass J, Norton J, Kohler RB, French ML. 
Cavitary histoplasmosis occurring during two large 
urban outbreaks. Analysis of clinical, epidemiologic, 
roentgenographic, and laboratory features. Medicine 
(Baltimore). 1984;63(4):201-209. doi:10.1097/00005792-
198407000-00002
70. Wheat LJ. Approach to the diagnosis of the endemic 
mycoses. Clin Chest Med. 2009;30(2):379-389, viii. 
doi:10.1016/j.ccm.2009.02.011
71. Stockman L, Clark KA, Hunt JM, Roberts GD. Evaluation 
of commercially available acridinium ester-labeled 
chemiluminescent DNA probes for culture identification 
of Blastomyces dermatitidis, Coccidioides immitis, 
Cryptococcus neoformans, and Histoplasma capsulatum. J 
Clin Microbiol. 1993;31(4):845-850.
72. Wheat LJ, Freifeld AG, Kleiman MB, et al; Infectious 
Diseases Society of America. Clinical practice guidelines 
for the management of patients with histoplasmosis: 2007 
update by the Infectious Diseases Society of America. Clin 
Infect Dis. 2007;45(7):807-825. doi:10.1086/521259
73. Brömel C, Sykes JE. Histoplasmosis in dogs and cats. 
Clin Tech Small Anim Pract. 2005;20(4):227-232. 
doi:10.1053/j.ctsap.2005.07.003
53ULJRI Vol 2, (2) 2018
